FDA device listing

cobas Cdiff Nucleic acid test for use on the cobas Liat System,cobas Cdiff Positive and Negative Control Kit for use on…

FDA device listing 1040213773 · Roche Diagnostics Operations Inc.

Key facts

Proprietary names cobas Cdiff Nucleic acid test for use on the cobas Liat System,cobas Cdiff Positive and Negative Control Kit for use on the cobas Liat System,KIT COBAS LIAT CDIFF Controls,KIT COBAS LIAT CDIFF IVD
Owner/operator Roche Diagnostics Operations Inc.
Owner/operator number 9039767
Premarket submissions K171770
Product codes OOI, OZN
Device names OOI - Real Time Nucleic Acid Amplification System, OZN - C. Difficile Toxin Gene Amplification Assay
Device class Class II
Classification regulations (21 CFR) 862.2570, 866.3130
Review panels Clinical Chemistry, Microbiology
Registered establishments ROCHE DIAGNOSTICS GMBH, ROCHE DIAGNOSTICS INTERNATIONAL LTD., ROCHE MOLECULAR SYSTEMS, INC.
Establishment registrations 2243471, 9610126, 3003795116, 3004141078
FEI numbers 2243471, 3002806559, 3003795116, 3004141078
Establishment operations Foreign Exporter, Manufacturer, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 1–9 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings